The precise redox control of AP-1 activation is essential for maintaining cellular homeostasis, and the dysregulation of AP-1 function has been implicated in numerous pathological conditions, including cancer, inflammation and neurodegenerative diseases. This evidence concerns the gene JUN and neurodegenerative disease.